Terumo Corporation (TYO:4543)

Market Cap	3.06T -26.3%
Revenue (ttm)	1.10T +8.3%
Net Income	127.90B +2.2%
EPS	86.69 +2.8%
Shares Out	1.48B
PE Ratio	23.89
Forward PE	19.96
Dividend	30.00 (1.45%)
Ex-Dividend Date	Mar 30, 2026

Volume	8,709,000
Average Volume	7,099,790
Open	2,039.50
Previous Close	2,044.50
Day's Range	2,038.50 - 2,090.00
52-Week Range	1,900.00 - 2,859.50
Beta	0.25
RSI	52.64
Earnings Date	May 14, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4543

Financial Performance

In fiscal year 2025, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.